Applied Pharmaceutical Analysis 2023
In-Person Event
September 26-28, 2023
Merck Research Laboratories, Boston, MA
Regulated Bioanalysis Workshop - Tuesday, September 26, 2023
Discovery Bioanalysis and New Technologies Workshop - Wednesday, September 27, 2023
Mechanistic ADME Workshop - Thursday, September 28, 2023
Agenda in Progress - Check Back for Updates
APA 2023 Program
![]() |
PLENARY LECTUREMelanie Anderson, PhDPrincipal Scientist @ Merck Merck's Strategy Around Decentralized Trials, Bioanalytical Sampling & Logistics |
|
|
![]() |
PLENARY LECTUREBhagwat Prasad, PhDPrincipal Investigator, Associate Professor @ Washington State University Quantitative Mass Spectrometry-based Multi-omics for Drug Development and Precision Medicine |
|
![]() |
Karan Agrawal, PhDScientist, Bioanalytical Discovery & Development @ Janssen Research & Development Evaluating a Hybrid LC-MS/MS Approach for the Quantification of siRNA Analytes |
![]() |
Suresh Paddigari, PhDTeam Lead @ Moderna RT-qPCR Method Development and Validation for mRNA Analysis |
![]() |
Liang Zhu, PhDDirector, Clinical Biomarker Laboratories @ Moderna Vaccine Bioanalysis Focused on Immunogenicity |
![]() |
Arkadeep Sinha, PhDBioanalytical Scientist @ EMD Serono Chasing the Matrix Interference in a Bispecific ADA Assay - Divergent Target Interference Based on a Patient Geography |
![]() |
Heather Cohen, PhDSenior Director, Translational Sciences @ Bicycle Therapeutics Peptide conjugates - Title TBA |
![]() |
Steven Louie, PhDSenior Principal Scientist @ Novartis Institutes for BioMedical Research Preclinical aspects of PROTACS - TBA |
![]() |
Upendra Dahal, PhDSenior Principal Scientist @ Amgen ADME Properties of SOTORASIB, a Covalent Drug for Treatment of KRAS G12C Addicted Tumors |
![]() |
Anette Karle, PhDSenior Principal Scientist Immunogenicity @ Novartis (Switzerland) MAPPS - title TBA |
![]() |
Edward Price, PhDSenior Scientist II, DMPK-BA @ AbbVie Mechanistic absorption models in the bRo5 chemical space - Title TBA |
![]() |
Joleen White, PhDHead of Bioassay Development & Operations @ Bill and Melinda Gates Medical Research Institute Patient Centric Sampling in the Therapeutic Development Programs
|
![]() |
Joe Cannon, PhDScientific Associate Director @ Bristol Myers Squibb Investigating Permeability of Heterobifunctional Protein Degraders |
![]() |
Yuting Wang, PhDSenior Scientist (DMPK-BA) @ AbbVie Bioanalytical Strategies for Characterization and PK Assessment of Multi-specific Antibodies |
Lei Ci, PhDAssociated Scientific Director @ Moderna Oligonucleotide-based therapeutics - Title TBA |
![]() |
Saravanan Ayyadurai, PhDSenior Scientist, Global DMPK @ Takeda NanoString-based High Throughput MicroRNA Biomarker Assay Development |
|
![]() |
Dhaval K. Shah, PhDAssociate Professor @ University at Buffalo School of Pharmacy and Pharmaceutical Sciences Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics |
![]() |
Bill Fitch, PhDAdjunct Professor, U.C. Santa Cruz, Chemistry & Biochemistry Department Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans. A Unique Challenge for MIST Assessment |
![]() |
Akshaya Ramesh, PhD Principal Bioinformatics Scientist @ Genentech Mass Spectrometry CSF Proteomics & Single-Cell Sequencing to Identify Novel Biomarkers in Multiple Sclerosis |
APA 2023 Sessions
Regulated Bioanalysis Workshop
Session I: The State of the FDA - Guidance, Approval, and Beyond
Session II: Emerging Modalities & New Technologies
Session III: Immunogenicity Applications for Various Drug Modalities
Discovery Bioanalysis and New Technologies Workshop
Session I: Biomarkers & Multi-Omics Data Integrations for Biomarker Discovery
Session II: Precision Medicine Applications
Session III: DMPK/Bioanalysis of PROTAC's
Mechanistic ADME Workshop
Session I: ADME of Select Modalities
Session II: Why is My Human ADMET Profile Not as Expected?
Session III: New Technology in ADME
Session IV: Unusual Biotransformation Pathways